Treatment with TMS at UCLA is administered under the guidance of the TMS Review Committee. The members of this Committee are all Board-Certified Psychiatrists and full-time professors of Psychiatry at UCLA, each with years of experience in the treatment of depression.

Individuals who are seeking care with TMS at UCLA are initially evaluated by one of the members of the Review Committee, and then that person's case is presented to the rest of the Committee for review and approval. In this way, we seek to ensure the highest quality of care for individuals with depression, whether that means treatment with TMS or some other recommendation. The Review Committee is chaired by Dr. Ian Cook, Director of the UCLA Depression Research and Clinic Program. He leads a Committee that includes members of the full-time UCLA faculty who are leading authorities in the management of depression: Drs. Espinoza, Gitlin, and Leuchter, shown below.

Treatment planning and stimulation sessions are conducted by Board-Certified Psychiatrists with specific training in brain stimulation techniques. At present, the four UCLA physicians on the treatment team are Drs. Cook, Espinoza, Gitlin, and Leuchter.

Treatments are administered in our state-of-the-art neuromodulation suite in the Semel Institute (Neuropsychiatric Institute) Building, 760 Westwood Blvd, Los Angeles, on the UCLA Campus (map, directions). For TMS treatments in depression, we employ the only FDA-approved system for therapeutic TMS, the NeuroStar TMS Therapy System (Neuronetics, Inc., Malvern PA).